Zdrowie i gospodarka · 02/10/2017

FDA Announces Fee Rate for Using Material Threat Medical Countermeasure Priority Review Voucher in FY 2018

The US Food and Drug Administration (FDA) has set the fee rate for using a material threat medical countermeasure (MCM) priority review voucher for fiscal year 2018, based on the average costs incurred in reviewing human drug applications in the previous year.